vTv Therapeutics, Inc. (VTVT)
33.95
+0.06
(+0.18%)
USD |
NASDAQ |
Aug 25, 09:59
vTv Therapeutics EPS Diluted (Quarterly) : -1.052 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.052 |
| March 31, 2026 | 1.649 |
| December 31, 2025 | -0.5752 |
| September 30, 2025 | -1.080 |
| June 30, 2025 | -0.9179 |
| March 31, 2025 | -0.7735 |
| December 31, 2024 | -0.552 |
| September 30, 2024 | -0.8766 |
| June 30, 2024 | -0.8089 |
| March 31, 2024 | -1.175 |
| December 31, 2023 | -1.668 |
| September 30, 2023 | -3.266 |
| June 30, 2023 | -2.758 |
| March 31, 2023 | -2.208 |
| December 31, 2022 | -2.329 |
| September 30, 2022 | -2.118 |
| June 30, 2022 | -1.791 |
| March 31, 2022 | -4.187 |
| December 31, 2021 | -4.223 |
| September 30, 2021 | -0.712 |
| June 30, 2021 | -0.4148 |
| March 31, 2021 | -3.004 |
| December 31, 2020 | 0.6056 |
| Date | Value |
|---|---|
| September 30, 2020 | -1.271 |
| June 30, 2020 | -2.950 |
| March 31, 2020 | -4.348 |
| December 31, 2019 | -5.304 |
| September 30, 2019 | -5.124 |
| June 30, 2019 | -4.112 |
| March 31, 2019 | -10.29 |
| December 31, 2018 | -4.151 |
| September 30, 2018 | -2.587 |
| June 30, 2018 | -12.40 |
| March 31, 2018 | -12.00 |
| December 31, 2017 | -17.60 |
| September 30, 2017 | -15.20 |
| June 30, 2017 | -16.40 |
| March 31, 2017 | -17.60 |
| December 31, 2016 | -16.80 |
| September 30, 2016 | -16.40 |
| June 30, 2016 | -18.80 |
| March 31, 2016 | -16.80 |
| December 31, 2015 | -14.00 |
| September 30, 2015 | -19.60 |
| June 30, 2015 | -38.72 |
| March 31, 2015 | -2.722 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | -0.4272 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.05M |
| Total Expenses (Quarterly) | 13.05M |
| Enterprise Value | 46.84M |
| Earnings Yield | -3.12% |
| Normalized Earnings Yield | -3.122 |